APHKX | MNCSX | APHKX / MNCSX | |
Total Expense Ratio | 0.97 | 0.62 | 156% |
Annual Report Gross Expense Ratio | 0.97 | 1.00 | 97% |
Fund Existence | 19 years | 4 years | - |
Gain YTD | 16.535 | 28.981 | 57% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 39.5B | 3.8B | 1,039% |
Annual Yield % from dividends | 2.28 | 4.15 | 55% |
Returns for 1 year | 8.08 | 19.58 | 41% |
Returns for 3 years | 59.21 | 65.83 | 90% |
Returns for 5 years | 69.49 | N/A | - |
Returns for 10 years | 84.55 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTDX | 126.01 | 2.56 | +2.07% |
Franklin Biotechnology Discovery C | |||
WGLSX | 13.31 | 0.17 | +1.29% |
Wasatch Long/Short Alpha Institutional | |||
TWQIX | 16.54 | -0.03 | -0.18% |
Transamerica Large Cap Value I | |||
OEICX | 96.12 | -0.30 | -0.31% |
JPMorgan Equity Index C | |||
NWAWX | 14.46 | -0.08 | -0.55% |
Nationwide GQG US Quality Eq Instl Ser |